On March 2, Shenzhen Yishi Kangning Biological Technology Co., Ltd. held the fifth anniversary celebration party in Nankunshan Grand View Garden. Five years ago, Professor Liu Yong, the inventor of ACTL's targeted anti-tumor immune technology, and his team established ISKCONN in Shenzhen, dedicated to the development and promotion of ACTL technology. They are convinced that, with strong belief, with unremitting pursuit, with love for the cause, with responsibility to society, ACTL technology will become the latest cancer treatment method.

In the past five years, Ishikoning, the seedling that has been carefully cared for by Ishikoning people, has withstood ups and downs and various ups and downs. After opening its strong body, the scars of the past are still faintly visible. However, ISKCON’s people have unique insights on scars—every painful injury, for this team with lofty ideals and strong desire to survive, it is an explosion of vitality and faster growth. Despite the scars, life is stronger.

Five years is just a moment in the long river of history, but these five years are full of hard work and struggle in the eyes of every ISKCONN. Ishikoning, which has gathered high-tech talents such as doctors and masters, has continuously introduced new anti-cancer technology products. At the same time, it has won the trust of experts and patients with its unique and efficient technical services, and has won market recognition.

Today's ISKCON is a national high-tech enterprise. Its patented technology, ACTL, continues to develop and mature. It can be used for the treatment of most tumors. It is the only anti-cancer immunotherapy technology that has won the Science and Technology Progress Award in China. The growth of ISKCON is increasingly receiving attention from the industry. The old seedling has grown into a small tree that can withstand wind, rain and hardship after five beatings in winter and summer.

Thinking about it carefully, the growth of ISKCONN is not only due to the struggle and pursuit of ISKCONN’s people. It also stems from catching up with such an era full of opportunities.

"Advancing with the times", ISKCON people understand the importance of development and innovation. Tomorrow will be an era full of opportunities and challenges. People call this era "the golden age of biopharmaceuticals" or "Internet +". It is still this road left to ISKCON’s people. Innovate and meet challenges.

The road ahead is far away, the road ahead is still bumpy, and the road ahead is equally difficult. ISKCON people always believe that hope and success are not only at the end of the road, but in the process of struggle.

Bless you, Yishi Kangning, sow hope along the way and reap success along the way!